Dermapharm Holding SE

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time

Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy

Dermapharm Holding SE: Christof Dreibholz, buy

Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies

Sustained organic growth in high-margin existing branded pharmaceutical business

Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share

Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE’s corporate strategy

Dermapharm Holding SE: Wilhelm Beier, buy

Dermapharm Holding SE: Anja Schorn, buy

Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

Dermapharm Holding SE builds on success in Q3 2023

Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall

Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment

Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy

Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share

Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit